Skip to content

Clinical trials

Completed Phase 1/2 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 1/2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20111
20131
20142
20151
20162
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic2
Abramson Cancer Center at Penn Medicine1
Craig McDonald, MD1
Horng Chen1
Instituto de Cardiologia do Rio Grande do Sul1
Murdoch Childrens Research Institute1
Nasser Aghdami MD., PhD1
Nikolay Kamenshchikov1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies10
Heart Failure3
Renal Insufficiency3
Acute Kidney Injury1
Breast Neoplasms1
Cardiomyopathy, Dilated1
Cardiotoxicity1
Coronary Artery Disease1
Friedreich Ataxia1
Heart Valve Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.